Estradiol 17-β represses insulin-like growth factor I receptor expression in smooth muscle cells from rabbit cardiac recipients

Transplantation

Volumn 66, Issue 4, 1998, Pages 419-426

  Lou, Hong ^a   Ramwell, Peter W ^a   Foegh, Marie L ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; ESTRADIOL; MESSENGER RNA; PLACEBO; RIBONUCLEASE; SOMATOMEDIN C RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA MEDIA; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; GENE REPRESSION; HEART TRANSPLANTATION; IMMUNOHISTOCHEMISTRY; INTRAMUSCULAR DRUG ADMINISTRATION; MALE; MITOGENICITY; NONHUMAN; PRIORITY JOURNAL; RABBIT; RECEPTOR DOWN REGULATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VASCULAR SMOOTH MUSCLE;

ANIMALS; CORONARY VESSELS; ESTRADIOL; HEART TRANSPLANTATION; MALE; MUSCLE, SMOOTH, VASCULAR; RABBITS; RECEPTOR, IGF TYPE 1; RNA;

EID: 0032572796     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199808270-00002     Document Type: Article

References (37)

1. Farhat MY, Lavigne MC, Ramwell PW. The vascular protective effects of estrogen. FASEB J 1996; 10: 615.
2. Foegh ML, Asotra S, Howell MH, Ramwell PW. Estradiol inhibition of arterial neointimal hyperplasia after balloon injury. J Vasc Surg 1994; 19: 722.
3. Foegh ML, Khirabadi BS, Nakanishi T, Vargas R, Ramwell PW. Estradiol protects against experimental cardiac transplant atherosclerosis. Transplant Proc 1987; 19 (suppl 5): 90.
4. Cheng LP, Kuwahara M, Jacobsson J, Foegh ML. Inhibition of myointimal hyperplasia and macrophage infiltration by estradiol in aorta allografts. Transplantation 1991; 52: 967.
5. Lou H, Kodama T, Zhao J, et al. Inhibition of transplant coronary arteriosclerosis in rabbits by chronic estradiol treatment is associated with abolition of MHC class II antigen expression. Circulation 1996; 95: 3355.
6. Lou H, Zao Y, Delafontaine P, et al. Estrogen effects on insulin-like growth factor-I (IGF-I) induced cell proliferation and IGF-I expression in native and allograft vessels. Circulation 1997; 96: 927.
7. Motomura N, Lou H, Hong M, et al. Local administration of estrogen inhibits transplant arteriosclerosis in rat aorta accelerated by topical exposure to IGF-I. Transplant Proc 1997; 29: 1118.
8. Ip JH, Fuster V, Badimon J, Taubman MB, Chesebro JH. Syndromes of accelerated atherosclerosis: role of vascular injury and smooth muscle cell proliferation. J Am Coll Cardiol 1990; 15: 1667.
9. Clark R. The somatogenic hormones and insulin-like growth factor-I: stimulators of lymphopoiesis and immune function. Endocrine Rev 1997; 18: 157.
10. Pfeifle B, Boeder H, Ditschuneit H. Interaction of receptors for insulin-like growth factor I, platelet derived growth factor, and fibroblast growth factor in rat aortic cells. Endocrinology 1987; 120: 2251.
11. Rubin R, Baserga R. Biology of disease, insulin-like growth factor-I receptor gene: its role in cell proliferation, apoptosis, and tumorogenicity. Lab Invest 1995; 73: 311.
12. LeRoith D, Werner H, Beitner-Johnson D, Roberts CT Jr. Molecular and cellular aspects of insulin-like growth factor I receptor. Endocrine Rev 1995; 16(2): 143.
13. DeAngelis T, Ferber A, Baser R. Insulin-like growth factor I receptor is required for the mitogenic and transforming activities of the platelet-derived growth factor receptor. J Cell Physiol 1995; 164: 214.
14. Miura M, Li SW, Dumenil G, Baserga R. Platelet-derived growth factor induced expression of messenger RNA for the proliferating cell nuclear antigen requires a functional receptor for the insulin-like growth factor I. Cancer Res 1994; 54: 2472.
15. Delafontaine P, Anwar A, Lou H, Ku L. G-protein coupled and tyrosine kinase receptors: evidence that activation of the insulin-like growth factor I receptor is required for thrombin-induced mitogenesis of rat aortic smooth muscle cells. J Clin Invest 1996; 97: 139.
16. Du J, Sperling LS, Marrero MB, Phillips L, Delafontaine P. G-protein and tyrosine kinase receptor cross-talk in rat aortic smooth muscle cells: thrombin- and angiotensin II-induced tyrosine phosphorylation of insulin receptor substrate-I and insulin-like growth factor I receptor. Biochem Biopsys Res Commun 1996; 218: 934.
17. Ververis JJ, Ku L, Delafontaine P. Regulation of insulin-like growth factor I receptors on vascular smooth muscle cells by growth factors and phorbol esters. Circ Res 1993; 72: 1285.
18. Jacobs S, Kull FC, Earp HS, Svoboda M, Van Wyk JJ, Cuatrecasas P. The phosphorylation somatomedin-C stimulates the beta-subunits of its own receptor. J Biol Chem 1983; 258: 9581.
19. Rubin M, Werner H, Gandini E, Roberts CT Jr, Le Roith D, Baserga R. Platelet-derived growth factor increases the activity of the promoter of the insulin-like growth factor I (IGF-I) receptor gene. Cancer Res 1994; 54: 2472.
20. Pietrzkowski Z, Lammers R, Carpenter G, et al. Constitutive expression of insulin-like growth factor I and insulin-like growth factor I receptor abrogates all requirements for exogenous growth factors. Cell Growth Differ 1992; 3: 199.
21. Kaleko M, Rutter WJ, Miller AD. Overexpression of the human insulin-like growth factor I receptor promotes ligand-dependent neoplastic transformation. Mol Cell Biol 1990; 10: 464.
22. Arteaga CL, Osborne CK. Growth inhibition of human breast cancer cell in vitro with an antibodies against the type I somatomedin receptor. Cancer Res 1989; 49: 6237.9.
23. Du J, Delafontaine P. Inhibition of vascular smooth muscle cell growth through antisense transcription of a rat insulin-like growth factor I receptor cDNA. Circ Res 1995; 76: 963.
24. Werner H, Woloschak M, Admo M, Shen-Orr Z, Robberts CT Jr, LeRoith D. Developmental regulation of rat insulin-like growth factor I receptors. Proc Natl Acad Sci USA 1989; 86: 7451.
25. Bornfeldt KE, Raines EW, Nakano T, Graves LM, Kurebs EG, Ross R. Insulin-like growth factor-I and platelet-derived growth factor-BB induce directed migration of human arterial smooth muscle cells via signaling pathways that are distinct from those of proliferation. J Clin Invest 1994; 93: 1266.
26. Polanco JI, Berciano MT, Miguel L Leon J, Pocovel M, Rodriguez-Rey JC. Expression of insulin-like growth factor I receptor mRNA in rabbit atherosclerotic lesions. Biochem Biophys Res Commun 1995; 209: 182.
27. Karas RH, Patterson BL, Mendelsohn ME. Human vascular smooth muscle cells contain functional estrogen receptor. Circulation 1994; 89: 1943.
28. Kim-Schulze S, McGowan KA, Hubchak SC, et al. Expression of estrogen receptor by human coronary artery and umbilical vein endothelial cells. Circulation 1996; 94: 1402.
29. Bei M, Lavigne MC, Foegh ML, Ramwell PW, Clarke R. Specific binding of 17 beta-estradiol to rat coronary artery smooth muscle cells. J Steroid Biochem Mol Biol 1996; 58: 83.
30. Iafrati MD, Karas RH, Aronovitz M, et al. Estrogen inhibits the vascular injury response in estrogen receptor α-deficient mice. Nat Med 1997; 3: 545.
31. Ignar-Trowbridge DM, Teng CT, Ross KA, Parker MG, Korach KS, McLachlan JA. Peptide growth factors elicit estrogen receptor-dependent transcriptional activation of an estrogen-responsive element. Mol Endocrinol 1993; 7: 992.
32. Ignar-Trowbridge DM, Pimentel M, Parker MG, McLachlan JA, Korach KS. Peptide growth factors cross talk with the estrogen receptor requires the A/B domain and occurs independently of protein kinase C or estradiol. Endocrinology 1996; 134: 1735.
33. Pettersson K, Grandien K, Kuiper GGJM, Gustafsson J. Mouse estrogen receptor β forms estrogen response element-binding heterodimers with estrogen receptor α. Mol Endocrinol 1997; 11: 1486.
34. Umayahara Y, Kawamori R, Watada H, et al. Estrogen regulation of the insulin-like growth factor-I gene transcription involves an AP-1. J Biol Chem 1994; 269: 16433.
35. Peach K, Webb P, Kuiper GGJM, et al. Differential ligand activation of estrogen receptors ERa and ER β at API sites. Science 1997; 277: 1508.
36. Krattenmacher R, Knauthe R, Parczyk K, Walker A, Hilgenfeldt U, Fritzemeier KH. Estrogen action on hepatic synthesis of angiotensinogen and IGF-I: direct and indirect estrogen effects. J Steroid Biochem Mol Biol 1994; 48: 207.
37. Murphy LJ. Impaired estrogen-induced uterine insulin-like growth factor-I gene expression in the streptozotocin diabetic rat. Diabetologia 1988; 31: 842.